College of American Pathologists (CAP) Annual Meeting 2025

Attend our lunch industry workshop and visit us at booth #218

We hope to see you at the College of American Pathologists (CAP) 2025 Annual Meeting, September 13–16, 2025, in Orlando, Florida.

Stop by the Thermo Fisher Scientific booth #218 for a live look at our sequencing and purification system. Learn how our solutions enable rapid genomic profiling in precision oncology and talk to our specialists about NGS testing, with tissue sample to report in as little as 24 hours.

We also invite you to attend our lunchtime industry workshop on September 15.

Register for our industry workshop

Introduction of new IVD solution for rapid NGS profiling in oncology

Date: September 15, 2025

Time: 12:00–1.30 pm EDT

Room: Cypress 1 Ballroom

During this workshop you’ll learn about:

Our new Oncomine Dx Express Test, an FDA-approved next-generation sequencing (NGS) companion diagnostic and tumor profiling test designed to specifically address the growing demand for biomarker testing in precision oncology. It offers rapid results in as little as 24 hours* while maximizing genomic insights.
The first experience with Oncomine Dx Express Test in the US by the team at Biodesix Inc.
Anatomic pathologists’ role in the future of genomic profiling in precision oncology

* Timing varies by number of samples and type of run.

Speakers

Alison Roos, PhD

Medical Affairs Director
Thermo Fisher Scientific

Gary Pestano, PhD

Chief Development Officer
Biodesix Inc.

Mahmoud Elsayad, MD, FCAP

Assistant Professor of Pathology and Medical Director
University of Texas Health Science Center

Featured solutions

Oncomine Dx Express Test US

The newly FDA-approved Oncomine Dx Express Test is designed to simplify the NGS workflow and connect patients everywhere to precision oncology. Capable of being implemented in even labs without NGS expertise close to patients, it delivers results within just 24 hours, from tissue sample to report.

Explore now

Genexus Dx System

The Ion Torrent Genexus Dx System is a clinical NGS platform for in vitro diagnostic (IVD) testing that delivers biomarker results in as little as 24 hours. This two-instrument system automates the main steps in the NGS workflow, including nucleic acid purification and quantification, library preparation, sequencing, bioinformatics analysis, and reporting.

The Genexus Dx Purification System and Genexus Dx Integrated Sequencer work together with Genexus Dx Software, tracking sample information and results automatically through the process.

Learn more

Services and support

Quality and efficiency in delivering patient test results shouldn’t be compromised under any circumstances. We can support your mission with our innovative services and expertise. From comprehensive support and a 98% uptime to continuing education to direct access to more than 2,000 OEM-certified service professionals, we’re here to help ensure the quality and efficiency of your work in delivering patient test results with confidence in your instruments and systems.

See support offerings